Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Company Profile

21:39 EDT 22nd March 2018 | BioPortfolio

News Articles [2127 Associated News Articles listed on BioPortfolio]

Novartis:FDA Approves Lutathera For Gastroenteropancreatic Neuroendocrine Tumors

BASEL (dpa-AFX) - Novartis AG (NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration (FDA) approval of its new d...

Novartis Closes Tender Offer For Advanced Accelerator Applications

BASEL (dpa-AFX) - Novartis AG (NVS) announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A., to buy all of the outstanding ordinary shares, including...

BridgeBio picks up shelved Novartis drug, kicks off new subsidiary

New BridgeBio subsidiary QED Therapeutics will develop Novartis' infigratinib in more than cancer.

Head to Head Analysis: Novartis (NVS) vs. Its Competitors

Novartis is one of 104 public companies in the "Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Novartis to related companies based on the strength of its earnings, ...

Novartis Commences Cash Tender Offer To Buy Advanced Accelerator Applications

BASEL (dpa-AFX) - Swiss drug major Novartis AG (NVS) announced Thursday that its subsidiary, Novartis Groupe France S.A. has commenced a cash tender offer to purchase Advanced Accelerator Applicat...

Report: Novartis Could Put Sandoz on the Auction Block Within a Few Weeks

Novartis may soon be looking to sell off its generics subsidiary Sandoz.

Novartis Closes Subsequent Offering Period Of Tender Offer For AAAP

BASEL (dpa-AFX) - Novartis AG (NVS) announced the completion of the subsequent offering period of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase all of the outstandin...

Novartis Names Elizabeth Barrett CEO, Novartis Oncology

BASEL (dpa-AFX) - Novartis (NVS) announced that Elizabeth Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the Executive Commi...

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Google, Novartis back Medicxi's ambitions.

First approval in sight for Novartis' CAR-T therapy after panel vote.

Novartis trial validates inflammasome as chronic disease driver.

Patent trend and competitive analysis of cancer immunotherapy in the United States.

Immunotherapy has brought high hopes for cancer treatment, and attracted tremendous resources from the biopharmaceutical community. Here we analyze cancer immunotherapy-related patents granted by the ...

Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine.

When faced with a diagnosis of multiple sclerosis (MS), patients often turn to the Internet and social media to find support groups, read about the experiences of other people affected by MS and seek ...

Clinical Trials [292 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Countries throughout the world are facing a growing non-communicable disease (NCD) burden. In developing countries, medicines to treat NCDs are often difficult to access or too expensive f...

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

The purpose of this study is to compare the single-dose oral bioavailability of oxcarbazepine 300 mg/5mL oral suspension of OHM Laboratories, USA (a subsidiary of Ranbaxy Pharmaceuticals I...

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

The study was conducted as an open label, balanced, randomized, two-treatment, two-period, two-sequence, single- dose, crossover bioavailability study comparing oxcarbazepine 300 mg/5mL or...

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subject (Aged 6 to 72 Months) Versus Control Vaccines

This study will evaluate the safety, tolerability and immunogenicity of one or two 0.25mL or 0.5mL intramuscular injections of influenza vaccine compared with control vaccine in subjects 6...

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

The primary objective of this observational, comparative safety study is to evaluate the safety of the Novartis Pandemic Influenza A (H1N1) vaccine in pregnant women and their off spring, ...

Companies [2346 Associated Companies listed on BioPortfolio]

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innova...

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical ...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product ca...

More Information about "Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG" on BioPortfolio

We have published hundreds of Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG news stories on BioPortfolio along with dozens of Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Clinical Trials and PubMed Articles about Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Companies in our database. You can also find out about relevant Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record